Basiliximab (anti-CD25) in combination with steriods may be an effective new treatment for steriod resistant ulcerative colitis

CSJ Probert, T Creed, MR Norman, C Dayan, SD Hearing, RF Harvey, IS Shaw, J Smithson, J Anderson, M Moorghen, J Gupta, NA Sheppard

Research output: Contribution to journalArticle (Academic Journal)peer-review

Translated title of the contributionBasiliximab (anti-CD25) in combination with steriods may be an effective new treatment for steriod resistant ulcerative colitis
Original languageEnglish
JournalAlimentary Pharmacology and Therapeutics
Publication statusPublished - 2003

Cite this